• Infinity Bio

  Participated · Series A · Jun 2025

  Infinity Bio develops a proprietary MIPSA platform for unbiased, high-resolution analysis of the antibody reactome to reveal immune targets across viruses, human proteins, and allergens. Since founding in 2023 the company has built a 9,000 square-foot laboratory in Baltimore and developed core services including HuSIGHT™, VirSIGHT™, AllerSIGHT™, and MuSIGHT™. Its platform is capable of processing thousands of samples per week and serves academic, government, and biopharma customers. Infinity Bio recently acquired the assets of Serimmune, Inc., broadening its suite of antibody reactome services. The company plans to use investment proceeds to expand its commercial footprint, accelerate MIPSA development, and launch new immune profiling services. New MIPSA service offerings, including EnviroSIGHT™, are expected to launch in the second half of 2025.

• Qualytics

  Participated · Equity · Dec 2022

  Qualytics provides an AI-driven, enterprise platform for augmented data quality that automates anomaly detection, intelligent rule generation, and remediation via no-code workflows. The platform integrates with cloud-native and legacy systems and tools including Databricks, Snowflake, SQL Server, Oracle, Atlan, and Alation. Qualytics surfaces more than 30,000 real-world anomalies per month and recently signed a top‑3 U.S. financial institution, demonstrating traction with large data-driven enterprises. The company reported 5x revenue growth over the past year, driven by demand for proactive data quality in AI and analytics initiatives. To support accelerating demand the company is scaling its team across engineering, product management, customer success, and sales. Planned product and go-to-market expansion aims to deepen platform capabilities, speed customer onboarding, and increase support for existing users. Qualytics provides an active, scalable data quality platform for enterprises. Led by CEO Gorkem Sevinc and based in Orlando, FL, it offers a scalable solution across the entire data quality lifecycle. The platform enables subject matter experts and data engineers to collaborate on data quality at scale through advanced automation and intelligent workflows. Qualytics raised $2.5M in funding in a round led by Tech Square Ventures. The company intends to use the funds to scale demand from Fortune 500 enterprises. The funding involved a mix of venture firms, funds and individual backers. Qualytics offers the Qualytics Data Firewall, a platform that monitors data with real-time surveillance. The platform uses advanced data operations and machine learning to enable governance, auditing, and data security by detecting data quality anomalies in real time and preventing bad data from entering downstream systems. The company is focused on a critical gap—data integrity. Qualytics was founded in April 2020 by Gorkem Sevinc and Dan Roche and is based in Baltimore, Md. The company operates as a tenant at the bwtech@UMBC Research & Technology Park. Its current financing activity includes an ongoing seed round with participation from institutional and angel investors.

• Scene Health

  Participated · Seed · Jun 2017

  Emocha Health is a Baltimore, Maryland-based digital health company that offers Digital Medication Adherence Programs enabling patients to take every dose via video technology and scalable human engagement. It partners with health plans, health systems, employers and health departments across the U.S. to improve adherence for patients with diabetes, asthma, tuberculosis and other chronic and infectious diseases. The company operates a remote clinical team of nurses and pharmacists that engages patients at scale. Emocha raised $6.2M in a Series A to expand strategic integrations and grow its remote clinical team. The funding is intended to help respond to demand from health plans and transplant centers across the United States. Sebastian Seiguer is CEO. emocha Mobile Health builds a mobile video technology platform used to support medication adherence for tuberculosis and other conditions. The platform is currently in use at sites in California and Puerto Rico and a Maryland phase showed 94% patient adherence and average public-health savings of $1,391 per patient. Researchers from Johns Hopkins School of Medicine will use a $1M NIH Small Business Innovation Research grant to evaluate the platform at those sites and at a third site in Minnesota where it is not yet in use; the study will run two years. The grant will also fund pilots in Guam and New Jersey. emocha is beginning a second phase of research, funded by a separate federal grant, to evaluate use of the platform for buprenorphine treatment for opioid addiction at the University of Washington and Boston Medical Center. The company has about 12 employees and is recruiting for roles in design and development. emocha Mobile Health is a Baltimore, MD-based medication adherence platform provider that uses video-based technology. The company closed a $1M seed funding round from a group of investors. It will use the funds to expand sales efforts and tailor the technology for opioid use disorder treatment. Led by CEO Sebastian Seiguer, emocha provides a video-based adherence platform powered by healthcare providers. The company works with payers, providers, and health departments to reduce costs and support patients with conditions such as tuberculosis, hepatitis C, and opioid addiction.

• Yet Analytics

  Participated · Seed · Jan 2017

  Yet Analytics is described in the article as a data-driven company based in Baltimore and led by CEO Shelly Blake-Plock. The piece does not detail specific products but frames the company around data-driven work and includes an interview referencing work with the U.S. Department of Defense. The company closed $1 million in new funding in early 2017. That raise brought Yet Analytics' total disclosed funding to $2.3 million following a seed round in November 2015. The article does not report revenue, user metrics, or specific product roadmaps. Yet Analytics offers a data-driven training platform for companies built on the DoD-developed xAPI standard. Its Yet Core standardizes job-training data from multiple sources to support integration with wearables, beacons, augmented reality and IoT. The company says the standardized data will gain value as those technologies develop. Yet has won recognition including Nielsen’s Data Visionary Award at TechCrunch Disrupt and a local pitch-win at Beta City. CEO Shelly Blake-Plock said the new capital will support hiring and execution. The company operates out of the Emerging Technology Centers’ Eastern Campus on 33rd Street in Baltimore.

• Citelighter

  Led · Seed · Jan 2015

  Citelighter offers student writing tools and a premium teacher/administrator service that enables assignment, monitoring and improvement of student work. The platform is available as free student tools or a paid premium service for teachers and administrators. Students in nearly 3,800 schools across more than 50 countries use Citelighter. Led by CEO Saad Alam, the company plans to use new funding to enhance the product, expand into additional schools, and grow headcount from 40 to 60 employees. The company is Baltimore, MD–based and targets K-12 education customers. The article reports a $2M Series Seed-2 raise to support these initiatives. Citelighter launched in fall 2011 as a platform and browser extension to help students manage online research, bibliographical data and citations. It built a learning database and tools that let students find relevant materials, automatically cite sources and collaborate via integrations with Google Docs and Microsoft Word. Observing classroom use, the company broadened its focus from a highlighting tool to an "all-purpose writing platform" that captures students' workflows. Citelighter is developing "Cognitive Prints," visualization tools that map each student's step-by-step writing process and produce color-coded, sequential logs teachers can use to analyze work habits. The founders intend the platform to help teachers improve writing proficiency by giving them detailed visibility into students' research and organization. Financially, the company has raised $1.5M from a mix of venture firms and angel investors to fund this product pivot. Citelighter, founded in fall 2011 and led by CEO Saad Alam, offers a browser-based research tool and extensions that let students capture facts, organize projects, export in-text citations, and generate bibliographies. The company launched a paid “Pro” tier that provides access to millions of credible academic articles from over 6,500 sources for $10 per month via a partnership with Cengage (starting with Questia). Pro surfaces premium content in curated "Knowledge Cards" assembled by a vetted team of 125 student "Knowledge Experts" and recommends material based on users’ research patterns. Citelighter has added Chrome and Safari plug-ins on top of an existing Firefox extension and plans to add PDF capture (to pull from Ebsco, JSTOR, and other databases) and social features around Knowledge Cards. The company is positioning itself as an Evernote-like capture tool tailored for students, differentiating from Zotero and Mendeley by focusing on quick, low-friction citation workflows. To support product expansion and Pro, Citelighter is raising a $750K seed round, with participation from media executives and entrepreneurs.

No current team members are available.